Tag Archives: solid tumors

June, 2018

  • 25 June

    AbbVie and Calibr Collaborate for Development of Next Generation T-Cell Therapies

    NORTH CHICAGO, Ill. and LA JOLLA, Calif., June 25, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Calibr, a nonprofit drug discovery division of Scripps Research, today announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors. This collaboration broadens AbbVie’s oncology research to access advanced precision …

May, 2018

April, 2018

January, 2018

December, 2017

November, 2017